SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 131 filers reported holding SCICLONE PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $49,482,000 | -0.6% | 4,581,672 | -5.7% | 0.01% | -10.0% |
| Q3 2016 | $49,797,000 | -15.3% | 4,858,275 | +7.9% | 0.01% | -23.1% |
| Q2 2016 | $58,817,000 | +173.4% | 4,503,620 | +130.3% | 0.01% | +160.0% |
| Q1 2016 | $21,512,000 | +20.8% | 1,955,613 | +1.0% | 0.01% | +25.0% |
| Q4 2015 | $17,810,000 | +25.7% | 1,935,853 | -5.2% | 0.00% | 0.0% |
| Q3 2015 | $14,173,000 | -27.3% | 2,042,170 | +2.9% | 0.00% | -20.0% |
| Q2 2015 | $19,488,000 | +4.4% | 1,984,500 | -5.8% | 0.01% | +25.0% |
| Q1 2015 | $18,667,000 | +3.7% | 2,106,932 | +2.6% | 0.00% | 0.0% |
| Q4 2014 | $17,997,000 | +38.8% | 2,054,472 | +9.2% | 0.00% | 0.0% |
| Q3 2014 | $12,967,000 | +28.2% | 1,882,050 | -2.1% | 0.00% | +33.3% |
| Q2 2014 | $10,113,000 | +1.7% | 1,922,620 | -12.1% | 0.00% | 0.0% |
| Q1 2014 | $9,947,000 | -6.3% | 2,186,051 | +3.8% | 0.00% | 0.0% |
| Q4 2013 | $10,611,000 | -1.7% | 2,105,379 | -1.2% | 0.00% | -25.0% |
| Q3 2013 | $10,799,000 | +16.9% | 2,129,938 | +14.4% | 0.00% | +33.3% |
| Q2 2013 | $9,236,000 | – | 1,862,167 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|